日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials

免疫检查点抑制剂在妇科癌症中的应用:改变临床实践的试验综述

Nasso, Cecilia; Puglisi, Silvia; Rebuzzi, Sara Elena; Errigo, Veronica; Rosa, Francesca; Chiola, Ilaria; Lazzari, Caterina; Musizzano, Yuri; Venturino, Ezio; Gastaldo, Alessandro; Siccardi, Caterina; Volpi, Eugenio Oreste; Mammoliti, Serafina; Benasso, Marco

1164P Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)

1164P 德国前瞻性 CRISP 注册真实世界队列研究 (AIO-TRK-0315) 中 COVID-19 大流行前后晚期 NSCLC 患者的患者报告结局

Mesía, R; Rivera, F; Kawecki, A; Rottey, S; Hitt, R; Kienzer, H; Cupissol, D; De Raucourt, D; Benasso, M; Koralewski, P; Delord, J-P; Bokemeyer, C; Curran, D; Gross, A; Vermorken, J B; Sebastian, M; Griesinger, F; von der Heyde, E; Dörfel, S; Wiegand, JH; Schiefer, C; Losem, C; Jänicke, M; Fleitz, A; Zacharias, S; Hipper, A; Dietel, C; Bleckmann, A; Benkelmann, R; Boesche, M; Grah, C; Müller, A; Eberhardt, WEE; Thomas, M

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

早期乳腺癌患者剂量密集型辅助化疗:Mammella InterGruppo (MIG)-1 III 期研究的 15 年结果

Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; Alonzo, Alessia D'; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia

Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis

吉西他滨联合放化疗治疗局部晚期头颈癌:文献系统综述和荟萃分析

Vanderveken, Olivier M; Szturz, Petr; Specenier, Pol; Merlano, Marco C; Benasso, Marco; Van Gestel, Dirk; Wouters, Kristien; Van Laer, Carl; Van den Weyngaert, Danielle; Peeters, Marc; Vermorken, Jan

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

评估EGFR基因拷贝数作为预测生物标志物在西妥昔单抗联合化疗一线治疗复发性和/或转移性头颈部鳞状细胞癌疗效中的应用价值:EXTREME研究

Licitra, L; Mesia, R; Rivera, F; Remenár, É; Hitt, R; Erfán, J; Rottey, S; Kawecki, A; Zabolotnyy, D; Benasso, M; Störkel, S; Senger, S; Stroh, C; Vermorken, J B